Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Sectra extends its pre-operative orthopaedic solution with DePuy Synthes 3D templates

Linköping, Sweden – October 2, 2019 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) is extending its pre-operative orthopaedic planning solution for trauma cases with 3D templates from one of the largest orthopaedic companies, DePuy Synthes. Pre-operative planning for trauma cases using templating in combination with 3D CT images enables improved surgical outcomes.“We are excited to provide orthopaedic surgeons with DePuy Synthes 3D templates in our pre-operative planning solution. We strongly believe that this capability will help

A clinical study with the VibroSense Meter concludes that the company's instruments can be used instead of the "Gold standard" for early detection of nerve damage in feet caused by type 1 diabetes

Doctor Eero Lindholm at Skåne University Hospital presented unique results from clinical study of Diabetic Peripheral Neuropathy (DPN) of feet in patients with type 1 diabetes. The results were presented at the world's second largest diabetes congress - EASD in Barcelona on September 17, 2019. The conclusion was that VibroSense technology and instruments can be used instead of Nerve Conduction Studies (NCS), for early diagnosis of nerve damage in feet caused by type 1 diabetes.Dr. Lindholm presented his results at a poster presentation. One of his conclusions was that he could see a

Year-End Report 18/19

September 2018 – August 2019, Diamyd Medical AB (publ), Fiscal year 2018/2019To preserve and regain the body’s own insulin productionDiamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com Figures in parentheses relate to the corresponding period previous financial year. September 1, 2018 – August 31, 2019 ·  Net income: MSEK 1.6 (0.8), whereof the fourth quarter MSEK 0.3 (0.1). The change refers to increased sales of GAD-protein for pre-clinical research. ·  Net result: MSEK -

Glaston initiates co-operation negotiations in its Finnish units due to weakening demand in heat treatment equipment - outlook for 2019 remains unchanged

Glaston Corporation      Inside information          2 October 2019             at 9 am EETGlaston Corporation initiates co-operation negotiations concerning measures to adapt the Glaston segment’s operations to lower than expected heat treatment equipment demand. The adaptation measures concern all companies in Finland within the Glaston segment. The co-operation negotiations concern both temporary lay-offs and termination of employment contracts. The company estimates that the negotiations could lead to the termination of approximately 20 employment contracts. These measures, in

Gapwaves completes a directed new share issue of 2,500,000 Class B shares, raising proceeds of approximately SEK 74 million

The board of directors of Gapwaves AB ("Gapwaves" or the "Company") has, as communicated in the Company's press release on 1 October 2019, resolved to carry out a new share issue of 2,500,000 Class B shares. The subscription price in the Directed New Share Issue amounts to SEK 29.50 per share, resulting in a discount of 8.6 percent compared to the volume weighted average price during the last thirty trading days. Through the Directed New Share Issue, Gapwaves will receive proceeds amounting to approximately SEK 74 million before transaction costs. Investors in the Directed New Share Issue

Expiry of subscription period for the Rights Issue today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES (OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL). THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Reference is made to previous announcements in respect of the ongoing Rights Issue of up to 25,000,000 new shares in Nordic Mining ASA . The subscription period for the Rights Issue will expire today, Wednesday 2 October 2019 at 16:30 (CEST). Correctly completed

Invitation to the presentation of Gjensidige's results for the 3rd quarter 2019

Gjensidige Forsikring Group (OSE:GJF) will publish the results for the 3rd quarter 2019 on 23 October at 7.00 CET. 23 October (Oslo) 9.00 CET CEO Helge Leiro Baastad and CFO Jostein Amdal will present the results in a combined webcast and conference call. The presentation and following Q&A session will be held in English. The webcast can be viewed live on www.gjensidige.no/ir. Participants who would like to ask questions should dial in using one of the telephone numbers below. The full presentation can also be listened to live, using the same dial-in details. Dial-in details:

Neste and Lufthansa collaborate and aim for a more sustainable aviation

Lufthansa image bank: Jens Görlich / Mo CGI Neste Corporation, Press Release, 2 October 2019, at 9 am (EET) Neste, the world’s leading renewable fuel producer, and Lufthansa, one of the leading airlines in Europe, strengthen their collaboration regarding the development of renewable solutions for aviation. As part of the collaboration, Lufthansa will use Neste’s sustainable aviation fuel, blended with fossil jet fuel on flights departing from Frankfurt. The first batch of sustainable aviation fuel was delivered to Lufthansa earlier this year.  “We are very happy to

Medicover raises EUR 120 million with inaugural schuldschein loan

Medicover AB (publ) has successfully carried out its first Schuldschein issue (a German private placement debt instrument), with a total of EUR 120 million in Euro-denominated tranches with maturities of 5 and 7 years, at fixed and floating rates. The issue was oversubscribed and increased from the initially offered EUR 100 million. With this transaction, Medicover was able to diversify its sources of financing and substantially expand the investor base, notably towards German, Asian and Polish institutional investors. Demand across all tranches was high, reflecting the company’s good

AcadeMedia grows the number of children and students by 3.4 percent organically

The number of children and students in AcadeMedia’s three school segments increased by 3.4 percent for the first quarter of 2019/20 compared with the corresponding period last year. During the quarter, the average number of children and students attending the AcadeMedia’s preschools and schools reached 81,468 (78,770). Growth in all three segments is purely organic. The figures are preliminary. Strong growth in AcadeMedia’s German preschoolsAs of July 1st, the Preschool Segment consists of preschools in Sweden, Norway and Germany. In Germany, six new preschools opened in August and

Physical activity and good fitness improve cardiac regulation in children

A recent Finnish study showed that more physically active and fit children have better cardiac regulation than less active and fit children. The study also showed that cardiac regulation was better especially in boys with better aerobic fitness and in girls with lower levels of sedentary time. The results, based on the Physical Activity and Nutrition (PANIC) Study conducted at the University of Eastern Finland, were published in the European Journal of Applied Physiology. Cardiovascular diseases cause a remarkable individual, public health, and economic burden globally. Cardiovascular

Nomination Committee 2020

In accordance with the resolution by Nyfosa’s annual general meeting of 2019, the chairman of the board of directors has convened a nomination committee for the annual general meeting 2020, appointed by the major shareholders in the company.The nomination committee consists of: ·  Johannes Wingborg, appointed by Länsförsäkringar Fondförvaltning AB (chairman of the nomination committee), ·  Lennart Francke, appointed by Swedbank Robur fonder, ·  Olof Nyström, appointed by Fjärde AP-fonden, ·  Daniel Klint, appointed by SEB fonder, and ·  Johan Ericsson, chairman of the board

Skanska builds clinical care building in Brookline, USA, for USD 40 M, about SEK 380 M

Skanska has signed a contract with The Children’s Hospital Corporation to construct a new ambulatory clinical care building, Boston Children’s at Brookline Place in Brookline, Massachusetts, USA. The contract is worth USD 40 M, about SEK 380 M, which will be included in the US order bookings for the third quarter of 2019.The project includes the fit-out of five levels of a 7,800-square-meter space, with a scope of work including clinical services and research space, equipment suites, reception areas, medical offices and a ground floor lobby. Construction begins in October 2019 and is

COSEL Group announces two technology leading products are finalists in the prestigious Elektra Awards

•    COSEL - RBC200F 200W AC/DC Power Supply tailored for small and medium robotics applications•    POWERBOX - ENI250A microprocessor controlled power supply for factory automation applicationsCosel Co, Ltd (6905: Tokyo) has announced that two leading products from the Cosel group, the COSEL RBC200F 200W AC/DC power supply tailored for small and medium robotics and the POWERBOX ENI250A microprocessor controlled power supply for factory automation applications have been selected by the Elektra Awards committee as a finalists in the highly contested Power System Product of the Year

New products from Fazer Bakeries: The widely popular Vihreät kuulat tähtitorttu star tartlet will also be part of this year’s Christmas

The Christmas flavours this year are as rich and succulent as ever: they include cherry, green marmalade balls, almonds and prunes. Fazer’s eye-catching and delicious Christmas products are an easy and tasty choice for crowning the Christmas table. Some of the new products will be available as early as from 7 October, so you can test them out well before Christmas.Something quick and easy to serve at Christmas: new and traditional Christmas products Fazer Illan Hehku pipari-kinuskikakkurulla, 485 g The Fazer Illan Hehku cake roll brings together all the lovely flavours of Christmas:

Multiconsult’s subsidiary LINK arkitektur wins a major contract for the new emergency hospital in Västerås

LINK arkitektur, in collaboration with Carlstedt Arkitekter as subcontractor, has signed a major contract with Region Västmanland for the architectural assignment of the 85,000 sqm new buildings at the new Västerås hospital in Sweden.The contract value is currently estimated to approximately SEK 20 million to LINK arkitektur for the first phase. In addition, the contract includes options for the following phases. The first phase will begin immediately and last for one year. The following phases will last until approximately 2023.In order to ensure the future of specialist healthcare in

Where to find skilled professionals for the construction industry?

YIT Corporation News October 2, 2019 at 07:30 a.m.We talk with experts about how to fill the shortage of skilled professionals in the construction sector to ensure a bright future for the industry.At YIT, the response to these challenges includes cooperation with education institutions and retraining, among other things.  The general trend in the construction industry has been positive over the past few years. Urbanisation has increased construction activity, particularly in major cities. In the Helsinki metropolitan area, significant investments including the architecturally

BAKKAFROST: Q3 2019 Trading Update

Harvest volumes in Q3 2019 are Farming North 3.7 thousand tonnesFarming West 9.2 thousand tonnesTotal Q3 2019 12.9 thousand tonnes   The harvest volumes are provided in head on gutted (HOG) equivalents. Feed sales in Q3 2019 are 33.9 thousand tonnes. Havsbrún sourced 17.8 thousand tonnes of raw materials in Q3 2019. The full Q3 2019 report will be released on 5 November 2019 at 06:00 CET.   Contacts: · Regin Jacobsen, CEO of P/F Bakkafrost: +298 23 50 01 (mobile) · Høgni Dahl Jakobsen, CFO of P/F Bakkafrost: +298 23 50 60 (mobile) This information is

Scandion Oncology applies for start of clinical Phase II trial in patients with metastatic colorectal cancer

Scandion Oncology A/S (“Scandion Oncology”) today announces that the company has submitted an application to the Danish Medicines Agency for permission to conduct a clinical Phase II study in patients with metastatic colorectal cancer. Scandion Oncology is thus following the timelines presented in the prospect. The study will be initiated at hospitals in Denmark. The clinical Phase II study will be conducted in two parts, and provided that the study is approved in the fourth quarter of 2019, the first data are expected in Q2 2020 and the final study report will be released in H1 2021.

In vivo animal data report on antibiotic resistance extended until mid-Q4 2019

Scandion Oncology A/S (“Scandion Oncology”) today announces that the report on the in vivo animal data on antibiotic resistance SOM-001 is extended until mid-Q4 2019 due to shortage in slots at the provider. This will not affect the company's goal of finding an overall strategy for commercializing SOM-001 in 2020.Earlier this year Scandion Oncology announced that a number of its compounds are able to overcome antibiotic resistance in bacterial infections through a different mechanism of action than the one related to reversing resistance to anti-cancer drugs in cancer cells. As previously

Temodex/SI053 will be presented at international conferences in North and South America

Temodex and Double Bond Pharmaceutical’s drug candidate SI053 will be presented at "Joint Conference of the Society for Neuro-Oncology and the Society for CNS Interstitial Delivery of Therapeutics on Therapeutic Delivery to the CNS" at November 20-21th (Phoenix, Arizona) and at "VII Congreso Massin, Society of International Neurosurgeons ”November 21-23 (Cartagene, Colombia). "I am pleased that we will present the experience with the use of Temodex and our development plans regarding SI053 to world experts in neuro-oncology on both American continents", - comments CEO Igor Lokot More

Exchange rates for the third quarter of 2019

The net foreign exchange impact of the Kindred Group’s main trading currencies against its reporting currency of GBP is shown in the tables below. While this has no material impact on the underlying development of the Kindred Group’s business, it does affect the reported results when translated into GBP. The weighted average impact of GBP against the Kindred Group’s main currencies was a positive impact on Gross winnings revenue of less than 1 per cent in the third quarter of 2019 compared to the same period of 2018. Balance sheet rates:          Rate to

Gapwaves announces intention of directed new share issue of B shares

Gapwaves AB ("Gapwaves" or the "Company") today announces its intention of a placement of approximately SEK 70 million to Swedish and international institutional investors. Gapwaves has engaged Pareto Securities AB ("Pareto Securities") to investigate the conditions for a new issue of Class B shares through a so-called accelerated bookbuilding.Gapwaves announces its intention to carry out a directed new share issue of approximately SEK 70 million, directed at qualified investors in Sweden and internationally (the "Directed New Share Issue"), which is intended to be carried out based on the

EAB GROUP PLC: ACQUISITION OF OWN SHARES 01.10.2019

EAB GROUP PLC  NOTIFICATION 01.10.2019 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 01.10.2019 Date 01.10.2019Exchange transaction BuyShare class EABAmount 220 Average price/share 2.8055 EUR  Highest price/share 2.8600 EUR Lowest price/share 2.8000 EUR Total price  617.21 EUR  The shares held by EAB Group Plc on 01.10.2019: EAB 2,085  On behalf of EAB Group Plc Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please

There are no items matching the current filter
There are no more items matching the current filter
Back to top